Skip to content

Study for safety and efficacy of fasting therapy of metabolic syndrome

Study for safety and efficacy of fasting therapy of metabolic syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR1900002845
Enrollment
Unknown
Registered
2019-12-17
Start date
2017-08-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Case series:Chinese traditional fasting

Sponsors

Sichuan Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Meet the Global consensus on Metabolic Syndrome of the International Diabetes Alliance, abdominal obesity (waist circumference >=90cm for men and >=80cm for women); 1. HDL-c (high-density lipoprotein cholesterol) 1.7mmol/L; 3. SBP (systolic blood pressure) >=130mmHg, or DBP (diastolic blood pressure) >=85mmHg; 4. FPG (fasting blood glucose) 5.6 to 11.1 mmol/L; 5. 9.0% or greater HbA1C; Participants are informed of this study and volunteered to participate in the study.

Exclusion criteria

Exclusion criteria: 1. type 1 DM or special type DM, or GDM; Serious complications of liver, kidney, brain, heart and other important organs and systems; 2. participants with other drug trials within the past 3 months; Antibiotics and microecological preparations were taken within 4 weeks; 3. poor blood glucose control and insulin injection >=30u; 4. secondary hypertension; 5. age =70 years; 6. associated with protein-wasting diseases; 7. diarrhea or other gastrointestinal diseases within the last 4 weeks; Previous history of gastrointestinal surgery.

Design outcomes

Primary

MeasureTime frame
Proteomics;the oxdiative stress factors;inflammation factors;body weight;

Countries

China

Contacts

Public ContactXiong Xiaoling
308132282@qq.com+86 15520776050

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026